Biotechs tighten belts, Hahn defends test policy: a BioCentury podcast

In the latest edition of the BioCentury This Week podcast, BioCentury Editor in Chief Simone Fishburn interviews Executive Editor Selina Koch about BioCentury’s survey of biotechs on how they are navigating the COVID-19 crisis, and Washington Editor Steve Usdin about the key takeaways from BioCentury’s conversation with FDA Commissioner Stephen Hahn.

The survey of 106 biotech companies by BioCentury and investment management firm Sanford C. Bernstein found biotechs are opting to defer equity financings and acquisitions, aiming to manage their way through the COVID-19 crisis by forming partnerships, cutting spending on payroll and programs, and taking on debt (see “Small Biotechs Tighten Belts, Seek Alternative Funding”)...